NCT04344769View on ClinicalTrials.gov

Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

RecruitingOBSERVATIONAL

Enrollment

40

Participants

Timeline

Start Date

October 4, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Autosomal Dominant Polycystic Kidney Disease

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Mayo Clinic

OTHER

NCT04344769 - Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Biotech Hunter | Biotech Hunter